کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4166218 | 1607496 | 2011 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Tetrahydrobiopterin Therapy for Phenylketonuria in Infants and Young Children Tetrahydrobiopterin Therapy for Phenylketonuria in Infants and Young Children](/preview/png/4166218.png)
ObjectiveTo describe patient selection, treatment administration, response evaluation, and side effect management associated with sapropterin therapy in infants and children aged <4 years.Study designSix case reports are presented from 4 US metabolic clinics treating phenylketonuria with sapropterin in patients aged 7 months to 4 years. Outcomes included blood phenylalanine (Phe) levels before and during treatment. For 3 of 6 cases, diet records were used to monitor changes in dietary Phe.ResultsSeverity of phenylketonuria ranged from mild to severe (classic). Treatment with sapropterin was safe and generally well tolerated. Blood Phe levels were reduced, or maximum dietary Phe tolerance was increased in patients with blood Phe that was well controlled by diet.ConclusionsGiven the increasing evidence that maintaining blood Phe levels below 360 μmol/L is important for the normal development of neurocognitive and behavioral function, sapropterin can be combined with a Phe-restricted diet to control blood Phe levels in young patients responsive to sapropterin therapy.
Journal: The Journal of Pediatrics - Volume 158, Issue 3, March 2011, Pages 410–415